Infusion related reactions in patients receiving 30-minute BRIUMVI infusions were all mild (Grade 1) and resolved completely Data also demonstrate...
During year 5 of treatment with BRIUMVI the annualized relapse rate was 0.020, equivalent to one relapse occurring every 50...
HLI is one of the most established, global longevity science companies and committed to accelerating living to 100+ years of...
HACKENSACK, N.J., Sept. 17, 2024 /PRNewswire/ -- On the morning of Wednesday, September 4, 2024, Hackensack Meridian Hackensack University Medical...
Telemedicine pioneer's quality resources and services are recognized by recent recertification FORT MYERS, Fla., Sept. 17, 2024 /PRNewswire/ -- TeleSpecialists,...
Preliminary immunogenicity results demonstrate induction of cancer antigen-specific T-cell responses in 77% of evaluable patients following CVGBM monotherapy84% of immune...
Marks first EMA submission for nipocalimab, an investigational treatment that binds with high affinity and specificity to block FcRn and...
Dr. Lloyd Minor and Prof Sir Menelas Pangalos bring significant scientific expertise and considerable experience in medicine research and developmentCAMBRIDGE,...
LAVAL, QC / ACCESSWIRE / September 11, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)...
PARAMUS, N.J., Sept. 10, 2024 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon...
A past-president of the American Spinal Injury Association, Dr. Tansey brings Lifeward over 30 years of experience in research and...
LIBERTYVILLE, Ill.--(BUSINESS WIRE)--#SaMD--JuneBrain is excited to announce our selection to receive a grant award from the Medical Device Innovation Consortium’s...
DENVER, Sept. 5, 2024 /PRNewswire/ -- Exer AI, a clinical AI company addressing musculoskeletal (MSK) and movement disorders, today announced a...
NANJING, China, Sept. 5, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets...
MIAMI, FL / ACCESSWIRE / September 4, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical-stage company...
SAN DIEGO, Sept. 3, 2024 /PRNewswire/ -- Cortechs.ai, the leader in volumetric neuroimaging analysis, announces FDA 510(k) clearance for its NeuroQuant®...
Dr Matthias Evers steps down as Chief Business Officer effective 01 October 2024Distribution of responsibilities across other Management Board functions...
New software updates bring expanded capability to the ECLIPSE Ji smart imaging system MELVILLE, N.Y., Aug. 29, 2024 /PRNewswire/ --...
Company provides update on regulatory progress towards US NDA submission TARRYTOWN, NY / ACCESSWIRE / August 27, 2024 / PaxMedica,...
The Centers for Medicare and Medicaid Services (CMS) assigned a new, unique Health Care Common Procedure Coding System (HCPCS) code...